Catalysis of 3-Carboxy-1,2-benzisoxazole Decarboxylation by Hydrophobic Antibody Binding Pockets
摘要:
Monoclonal antibodies were generated against a 3-phenyl-1,2-benzisoxazole derivative and shown to catalyze the solvent-sensitive decarboxylation of 3-carboxy-1,2-benzisoxazoles. In addition to rare accelerations up to 2300-fold over background, the antibodies exhibit distinctive selectivities for substrates bearing 5- or 6-NO2 substituents, with preferential decarboxylation of the less reactive substrate in one case. These effects are the likely consequence of substrate destabilization, achieved by forcing the carboxylate group into a relatively apolar binding pocket and stabilization of the charge-delocalized transition state through dispersive interactions. Comparison with a more active antibody decarboxylase previously raised against 2-acetamido-naphthalene-1,5-disulfonate suggests, however, that a judicious mix of polar and apolar interactions may ultimately be more effective for achieving high decarboxylase activity.
Rhodium(<scp>iii</scp>)-catalysed redox neutral alkylation of 3-arylbenzo[<i>d</i>]isoxazoles: easy access to substituted succinimides
作者:Xuelin Yue、Xiang Zhao、Junwei Huang、Yijie Gao、Yadong Feng、Xiuling Cui
DOI:10.1039/d3ob00851g
日期:——
A convenient method for the alkylation of 3-arylbenzo[d]isoxazoles with maleimides under redox-neutral conditions has been developed, giving a series of substituted succinimides in up to 99% yield. This transformation is highly selective to give succinimides, and Heck-type products are successfully avoided. This protocol features 100% atom-economy and broad substrate tolerance, and provides a novel
开发了一种在氧化还原中性条件下用马来酰亚胺对3-芳基苯并[ d ]异恶唑进行烷基化的简便方法,得到一系列取代的琥珀酰亚胺,产率高达 99%。这种转化对于得到琥珀酰亚胺具有高度选择性,并且成功地避免了 Heck 型产物。该方案具有100%原子经济性和广泛的底物耐受性,为合成多种琥珀酰亚胺提供了一种新策略,为蛋白质药物的琥珀酰化和药理学家发现一流药物提供了机会。